Bioequivalence of finasteride tablet in healthy volunteers by LC-MS/MS
Ying Zhang
Abstract
Ying Zhang
Abstract
OBJECTIVE To study the pharmacokinetics and bioequivalence of finasteride tablets in 24 healthy male volunteers by LC-MS/MS assay.METHODS A single oral dose 1 mg of test tablets and reference tablets were given to each volunteers according to an open randomized crossover design.The concentration of finasteride in plasma was determined by LC-MS/MS.The pharmacokinetic parameters were calculated and the bioequivalence was compared.RESULTS The main pharmacokinetic parameters of the test and reference preparations were as follows:AUC0-36 were(50.317±22.478) and(48.586±22.345)μg.h.L-1;AUC0-∞ were(52.939±24.352) and(50.880±23.837)μg.h.L-1;Tmax were(1.77±0.44) and(1.79±0.41) h;Cmax were(7.758±3.314) and(7.852±3.456)μg.L-1;t1/2 were(5.10±1.33) and(4.96±1.25) h.The relative bioavailability was(106.0±20.9)%.The main pharmacokinetic parameters showed no statistically significant difference between 2 preparations.CONCLUSION The 2 preparations were bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To study the pharmacokinetics and bioequivalence of finasteride tablets in 24 healthy male volunteers by LC-MS/MS assay.METHODS A single oral dose 1 mg of test tablets and reference tablets were given to each volunteers according to an open randomized crossover design.The concentration of finasteride in plasma was determined by LC-MS/MS.The pharmacokinetic parameters were calculated and the bioequivalence was compared.RESULTS The main pharmacokinetic parameters of the test and reference preparations were as follows:AUC0-36 were(50.317±22.478) and(48.586±22.345)μg.h.L-1;AUC0-∞ were(52.939±24.352) and(50.880±23.837)μg.h.L-1;Tmax were(1.77±0.44) and(1.79±0.41) h;Cmax were(7.758±3.314) and(7.852±3.456)μg.L-1;t1/2 were(5.10±1.33) and(4.96±1.25) h.The relative bioavailability was(106.0±20.9)%.The main pharmacokinetic parameters showed no statistically significant difference between 2 preparations.CONCLUSION The 2 preparations were bioequivalent.
Key concepts: Bioequivalence, Pharmacokinetics, Cmax, Bioavailability, Finasteride, Crossover study, Pharmacology, Medicine